Magellan Health (MGLN) to Release Earnings on Thursday

Magellan Health (NASDAQ:MGLN) will be releasing its earnings data before the market opens on Thursday, February 22nd. Analysts expect Magellan Health to post earnings of $2.30 per share for the quarter.

Magellan Health (MGLN) opened at $94.75 on Thursday. The stock has a market cap of $2,270.79, a PE ratio of 25.00, a PEG ratio of 1.11 and a beta of 0.52. The company has a current ratio of 2.28, a quick ratio of 2.21 and a debt-to-equity ratio of 0.62. Magellan Health has a 1 year low of $64.05 and a 1 year high of $102.70.

In other news, General Counsel Daniel N. Gregoire sold 8,275 shares of the stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $89.08, for a total transaction of $737,137.00. Following the completion of the transaction, the general counsel now directly owns 16,690 shares of the company’s stock, valued at approximately $1,486,745.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Clapper Caskie Lewis sold 59,313 shares of the stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $93.99, for a total transaction of $5,574,828.87. Following the transaction, the insider now directly owns 48,474 shares of the company’s stock, valued at $4,556,071.26. The disclosure for this sale can be found here. In the last quarter, insiders sold 113,953 shares of company stock valued at $10,797,505. Company insiders own 5.00% of the company’s stock.

A number of equities research analysts recently weighed in on the stock. ValuEngine upgraded shares of Magellan Health from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. BidaskClub lowered shares of Magellan Health from a “strong-buy” rating to a “buy” rating in a report on Tuesday, December 19th. Raymond James Financial restated a “hold” rating on shares of Magellan Health in a report on Saturday, December 2nd. KeyCorp set a $105.00 target price on shares of Magellan Health and gave the stock a “buy” rating in a report on Friday, December 1st. Finally, Zacks Investment Research upgraded shares of Magellan Health from a “hold” rating to a “strong-buy” rating and set a $112.00 target price on the stock in a report on Wednesday, December 13th. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $96.00.

TRADEMARK VIOLATION WARNING: “Magellan Health (MGLN) to Release Earnings on Thursday” was originally published by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/02/15/magellan-health-mgln-to-release-earnings-on-thursday.html.

Magellan Health Company Profile

Magellan Health, Inc is engaged in the healthcare management business. The Company’s segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC).

Earnings History for Magellan Health (NASDAQ:MGLN)

Receive News & Ratings for Magellan Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Magellan Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply